An imidazolium ion with an alkyl substituent at the 1-position and a methyl substituent at the 3-position.
ChEBI ID: 61321
| Member | Definition | Role |
|---|---|---|
| 1-butyl-3-methylimidazolium | A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is butyl. | 1-butyl-3-methylimidazolium |
| 1-dodecyl-3-methylimidazolium | A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is dodecyl. | 1-dodecyl-3-methylimidazolium |
| 1-hexyl-3-methylimidazolium | A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is hexyl. | 1-hexyl-3-methylimidazolium |
| 1-methyl-3-ethylimidazolium | A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is ethyl. | 1-ethyl-3-methylimidazolium |
| buclizine | A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is octyl. | 3-methyl-1-octylimidazolium |
| promethazine | A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is methyl. | 1,3-dimethylimidazolium |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (0.21) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 43 (8.98) | 29.6817 |
| 2010's | 390 (81.42) | 24.3611 |
| 2020's | 45 (9.39) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 6 (1.18%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 501 (98.82%) | 84.16% |